Prot #RXI-109-1402: An Open-Label, Multi-Center, Prospective, Within-Subject Controlled, Phase 2a Study to Evaluate the Effectiveness and Safety of RXI -109 on the Outcome of Scar Revision Surgery for Hypertrophic Scars in Healthy Adults

Project: Research project

Project Details

StatusFinished
Effective start/end date12/11/14 → 12/11/17

Funding

  • RXi Pharmaceuticals Corporation (RXI-109-1402)